The ROE as of July 2025 (TTM) for Edesa Biotech, Inc. (EDSA) is -103.09%

According to Edesa Biotech, Inc.’s latest financial reports and current stock price. The company's current ROE is -103.09%. This represents a change of 118.86% compared to the average of -47.10% of the last 4 quarters.

Edesa Biotech, Inc. (EDSA) Historical ROE (quarterly & annually)

How has EDSA ROE performed in the past?

The mean historical ROE of Edesa Biotech, Inc. over the last ten years is -105.60%. The current -103.09% ROE has changed -2.38% with respect to the historical average. Over the past ten years (40 quarters), EDSA's ROE was at its highest in in the June 2015 quarter at 4.92%. The ROE was at its lowest in in the December 2024 quarter at -71.43%.

Edesa Biotech, Inc. (EDSA) ROE by Quarter and Year

Discovering the peaks and valleys of Edesa Biotech, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Edesa Biotech, Inc. (EDSA) Average ROE

How has EDSA ROE performed in the past?

The current ROE of Edesa Biotech, Inc. (EDSA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Edesa Biotech, Inc. (EDSA) ROE vs. Peers

How is EDSA’s ROE compared to its peers?

Edesa Biotech, Inc.’s ROE is greater than SAB Biotherapeutics, Inc. (-105.14%), greater than Senti Biosciences, Inc. (-177.25%), greater than Cingulate Inc. (-473.25%), greater than Bellicum Pharmaceuticals, Inc. (-189.12%), greater than Hillstream BioPharma, Inc. (-550.15%), greater than NeuroBo Pharmaceuticals, Inc. (-222.13%), greater than Indaptus Therapeutics, Inc. (-333.04%), less than Pasithea Therapeutics Corp. (-0.42%), less than Quoin Pharmaceuticals, Ltd. (-0.45%), greater than Lixte Biotechnology Holdings, Inc. (-237.47%), less than Comera Life Sciences Holdings, Inc. (172.01%), greater than SAB Biotherapeutics, Inc. (-105.14%), greater than Processa Pharmaceuticals, Inc. (-319.58%), greater than Fresh Tracks Therapeutics, Inc. (-66.50%), greater than Third Harmonic Bio, Inc. (-19.27%), greater than Aditxt, Inc. (-276.86%), greater than Palisade Bio, Inc. (-178.91%), less than Plus Therapeutics, Inc. (238.98%), greater than Revelation Biosciences, Inc. (-505.44%), greater than Nutriband Inc. (-113.25%), greater than Longeveron Inc. (-85.06%), greater than RenovoRx, Inc. (-119.58%), greater than Virax Biolabs Group Limited (-91.77%),

Build a custom stock screener for Edesa Biotech, Inc. (EDSA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Edesa Biotech, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Edesa Biotech, Inc. (EDSA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Edesa Biotech, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.